MarketPulse

Medicare reimbursement

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Anteris Lands Medicare Reimbursement for PARADIGM Heart Valve Trial

Anteris Technologies secures CMS reimbursement eligibility for its PARADIGM Trial evaluating DurAVR transcatheter heart valve in 1,000 patients, accelerating U.S. site activation.
AVRclinical trialPARADIGM Trial
GlobeNewswire Inc.GlobeNewswire Inc.··Coloplast A/S

Coloplast Slashes Growth Outlook as Kerecis Struggles Post-Medicare Changes

Coloplast cuts FY 2025/26 guidance citing Kerecis underperformance following Medicare reimbursement changes, taking DKK 3B impairment charge.
CLPBYorganic growthwound care
The Motley FoolThe Motley Fool··Eric Volkman

NeuroPace Beats Earnings Expectations, But 2026 Outlook Cools Rally

NeuroPace shares rose nearly 1% after Q4 earnings beat expectations with $26.6M revenue (24% YoY growth) and narrowed losses, though 2026 guidance disappointed investors.
NPCEnet lossrevenue growth